Dynavax to Present at the Jefferies Global Healthcare Conference

Dynavax to Present at the Jefferies Global Healthcare Conference 
BERKELEY, CA -- (Marketwired) -- 06/02/14 --  Dynavax Technologies
Corporation (NASDAQ: DVAX) announced today that it will present at
the Jefferies Global Healthcare Conference in New York on Thursday,
June 5, 2014 at 2:30 p.m. Eastern Time (11:30 a.m. Pacific Time).  
Michael Ostrach, Chief Business and Principal Financial Officer of
Dynavax, will provide a company overview. To access the slide
presentation, live webcast, and subsequent archived recording, please
visit Dynavax's website at
http://investors.dynavax.com/newsevents.cfm.  
About Dynavax 
Dynavax, a clinical-stage biopharmaceutical company, discovers and
develops novel vaccines and therapeutics in the areas of infectious
and inflammatory diseases and oncology. Dynavax's lead product
candidate is HEPLISAV-B, a Phase 3 investigational adult hepatitis B
vaccine. For more information visit www.dynavax.com. 
Contact:
Michael Ostrach
Chief Business and Principal Financial Officer 
510-665-7257
mostrach@dynavax.com 
 
 
Press spacebar to pause and continue. Press esc to stop.